DUBLIN--(BUSINESS WIRE)--The "Global Cancer Diagnostics Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Cancer Diagnostics Market is poised to grow strong during the forecast period 2017 to 2027
Some of the prominent trends that the market is witnessing include Prevalence of Cancer Cases, Government Initiatives for Funding and Awareness about Cancer and Growing Medical Tourism in Asia.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 Technology Analysis
1.5 Application Analysis
1.6 End User Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Prevalence Of Cancer Cases
3.1.2 Government Initiatives For Funding And Awareness About Cancer
3.1.3 Growing Medical Tourism In Asia
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Cancer Diagnostics Market, By Method
4.1 Endoscopy
4.2 Tumor Biomarker Tests
4.2.1 AFP Tests
4.2.2 ALK Tests
4.2.3 BRCA Tests
4.2.4 CA-19 Tests
4.2.5 CEA Tests
4.2.6 CTC Tests
4.2.7 EGFR Mutation Tests
4.2.8 HER2 Tests
4.2.9 KRAS Mutation Tests
4.2.10 PSA Tests
4.3 Laboratory Tests
4.4 Genetic Tests
4.5 Other Methods
4.5.1 Barium Enema
5 Cancer Diagnostics Market, By Technology
5.1 Instrument-Based
5.1.1 Diagnostic Imaging
5.1.1.1 Computed Tomography (Ct)
5.1.1.2 Magnetic Resonance Imaging (MRI)
5.1.1.3 Positron Emission Tomography (PET)
5.1.1.3.1 Standalone Positron Emission Tomography
5.1.1.3.2 Hybrid Positron Emission Tomography
5.1.1.4 Mammography
5.1.1.5 Ultrasound
5.1.2 Biopsies
5.1.2.1 Needle Biopsy
5.1.2.2 Endoscopic Biopsy
5.1.2.3 Bone Marrow Biopsy
5.1.3 Liquid Biopsy
5.2 Platform-Based Diagnostics
5.2.1 Flow Cytometry
5.2.2 Immunohistochemistry (IHC)
5.2.3 In Situ Hybridization (ISH)
5.2.4 Microarrays
5.2.5 Next-Generation Sequencing (NGS)
5.2.6 Polymerase Chain Reaction (PCR)
5.2.7 Other Technologies
6 Cancer Diagnostics Market, By Application
6.1 Breast Cancer
6.2 Lung Cancer
6.3 Colorectal Cancer
6.4 Melanoma
6.4.1 Non-Hodgkin Lymphoma
6.4.2 Thyroid Cancer
6.4.3 Pancreatic Cancer
6.4.4 Prostate cancer
6.5 Kidney Cancer
6.6 Liver Cancer
6.7 Cervical Cancer
6.8 Ovarian cancer
6.9 Blood cancer
6.10 Other Applications
6.10.1 Esophageal cancer
6.10.2 Brain cancer
7 Cancer Diagnostics Market, By End User
7.1 Hospitals
7.2 Cancer Research Institutes
7.3 Diagnostic Laboratories
8 Cancer Diagnostics Market, By Geography
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Middle East
8.5 Latin America
8.6 Rest of the World (RoW)
9 Key Player Activities
9.1 Acquisitions & Mergers
9.2 Agreements, Partnerships, Collaborations and Joint Ventures
9.3 Product Launch & Expansions
9.4 Other Activities
10 Leading Companies
- Abbott Labs
- Applied Imaging Corporation
- Arcturus Engineering
- Autogenomics Incorporated
- Bayer Corporation, Diagnostics Division
- Biocurex, Inc.
- Biomedical Diagnostics, Llc
- Biomoda Inc.
- Biosource International, Inc.
- Celera Diagnostics
- Chromavision Medical Systems, Inc.
- Ciphergen Biosystems, Inc
- Correlogic Systems, Inc.
- Cytyc Corporation
- Diagnostic Product Corporation (Dpc)
For more information about this report visit https://www.researchandmarkets.com/research/4ww633/global_cancer?w=4
